Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125177884 | 12517788 | 4 | F | 20160307 | 20160916 | 20160630 | 20160919 | EXP | BE-ABBVIE-16P-013-1590828-00 | ABBVIE | 49.00 | YR | M | Y | 81.00000 | KG | 20160919 | MD | COUNTRY NOT SPECIFIED | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125177884 | 12517788 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 1052069 | 207931 | 2 | DF | TABLET | QD | ||||||
| 125177884 | 12517788 | 2 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1052069 | 207931 | |||||||||||
| 125177884 | 12517788 | 3 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1052069 | 207931 | |||||||||||
| 125177884 | 12517788 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNKNOWN | 0 | TABLET | |||||||||
| 125177884 | 12517788 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | UNKNOWN | 0 | |||||||||||
| 125177884 | 12517788 | 6 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | UNKNOWN | 0 | |||||||||||
| 125177884 | 12517788 | 7 | C | TRAMADOL. | TRAMADOL | 1 | DRUG INTRODUCED DURING CHC TREATMENT | 0 | |||||||||||
| 125177884 | 12517788 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | DRUG INTRODUCED DURING CHC TREATMENT | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125177884 | 12517788 | 1 | Chronic hepatitis C |
| 125177884 | 12517788 | 2 | Chronic hepatitis C |
| 125177884 | 12517788 | 3 | Chronic hepatitis C |
| 125177884 | 12517788 | 4 | Chronic hepatitis C |
| 125177884 | 12517788 | 5 | Chronic hepatitis C |
| 125177884 | 12517788 | 6 | Chronic hepatitis C |
| 125177884 | 12517788 | 7 | Product used for unknown indication |
| 125177884 | 12517788 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125177884 | 12517788 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125177884 | 12517788 | Facial paresis | |
| 125177884 | 12517788 | Headache | |
| 125177884 | 12517788 | Medical device removal | |
| 125177884 | 12517788 | Postoperative wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125177884 | 12517788 | 1 | 20160216 | 20160801 | 0 | |
| 125177884 | 12517788 | 4 | 20160216 | 20160801 | 0 |